How Gamida Cell’s FDA Approval Could Reduce Racial Disparities in Stem Cell Transplants

The FDA approved Omisirge, an allogeneic cell therapy from Gamida Cell that could improve access to stem cell transplants as treatments for blood cancers. The biotech makes its therapy from umbilical cord blood.